Home LiteratureArticle Details
PMID: 26961683 Published · epublish English Journal Article Research Support, N.I.H., Extramural

CoINcIDE: A framework for discovery of patient subtypes across multiple datasets.

Genome medicine ·Vol. 8 ·No. 1 ·2016-03-09 ·Pages 27

Planey CR, Gevaert O

Abstract

Patient disease subtypes have the potential to transform personalized medicine. However, many patient subtypes derived from unsupervised clustering analyses on high-dimensional datasets are not replicable across multiple datasets, limiting their clinical utility. We present CoINcIDE, a novel methodological framework for the discovery of patient subtypes across multiple datasets that requires no between-dataset transformations. We also present a high-quality database collection, curatedBreastData, with over 2,500 breast cancer gene expression samples. We use CoINcIDE to discover novel breast and ovarian cancer subtypes with prognostic significance and novel hypothesized ovarian therapeutic targets across multiple datasets. CoINcIDE and curatedBreastData are available as R packages.

MeSH Terms
Algorithms Breast Neoplasms/diagnosis,genetics Cluster Analysis Computational Biology/methods Computer Simulation Datasets as Topic Female Gene Expression Profiling Humans Ovarian Neoplasms/diagnosis,genetics Prognosis ROC Curve Software
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Planey Catherine R
The Stanford Center for Biomedical Informatics Research (BMIR), Department of Medicine, Stanford University, 1265 Welch Road, Stanford, CA, 94305, USA.
Gevaert Olivier
The Stanford Center for Biomedical Informatics Research (BMIR), Department of Medicine, Stanford University, 1265 Welch Road, Stanford, CA, 94305, USA. ogevaert@stanford.edu.
References (26)
26 references, click to expand
  1. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
    J Clin Invest. 2011 Jul;121(7):2750-67 PMID: 21633166
  2. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    BMC Med Genomics. 2012;5:44 PMID: 23035882
  3. Are clusters found in one dataset present in another dataset?
    Biostatistics. 2007 Jan;8(1):9-31 PMID: 16613834
  4. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation.
    J Exp Med. 2013 Oct 21;210(11):2205-21 PMID: 24127489
  5. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.
    J Clin Oncol. 2004 Mar 15;22(6):1103-9 PMID: 15020612
  6. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
    Neuro Oncol. 2009 Dec;11(6):833-41 PMID: 19332771
  7. Supervised risk predictor of breast cancer based on intrinsic subtypes.
    J Clin Oncol. 2009 Mar 10;27(8):1160-7 PMID: 19204204
  8. Molecular portraits of human breast tumours.
    Nature. 2000 Aug 17;406(6797):747-52 PMID: 10963602
  9. Integrated genomic analyses of ovarian carcinoma.
    Nature. 2011 Jun 30;474(7353):609-15 PMID: 21720365
  10. Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.
    Clin Cancer Res. 2013 Oct 1;19(19):5533-40 PMID: 23948975
  11. Repeated observation of breast tumor subtypes in independent gene expression data sets.
    Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23 PMID: 12829800
  12. Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells.
    Cancer Chemother Pharmacol. 2007 May;59(6):711-23 PMID: 17021820
  13. The molecular portraits of breast tumors are conserved across microarray platforms.
    BMC Genomics. 2006;7:96 PMID: 16643655
  14. Community structure in social and biological networks.
    Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7821-6 PMID: 12060727
  15. Adjusting batch effects in microarray expression data using empirical Bayes methods.
    Biostatistics. 2007 Jan;8(1):118-27 PMID: 16632515
  16. Comprehensive molecular portraits of human breast tumours.
    Nature. 2012 Oct 4;490(7418):61-70 PMID: 23000897
  17. Eigengene networks for studying the relationships between co-expression modules.
    BMC Syst Biol. 2007;1:54 PMID: 18031580
  18. Validated gene targets associated with curatively treated advanced serous ovarian carcinoma.
    Gynecol Oncol. 2013 Mar;128(3):512-7 PMID: 23168173
  19. The druggable genome.
    Nat Rev Drug Discov. 2002 Sep;1(9):727-30 PMID: 12209152
  20. curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome.
    Database (Oxford). 2013;2013:bat013 PMID: 23550061
  21. A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen.
    Clin Cancer Res. 2012 Aug 15;18(16):4465-72 PMID: 22711706
  22. Critical limitations of consensus clustering in class discovery.
    Sci Rep. 2014;4:6207 PMID: 25158761
  23. NCBI GEO standards and services for microarray data.
    Nat Biotechnol. 2006 Dec;24(12):1471-2 PMID: 17160034
  24. Molecular subtypes of high-grade serous ovarian cancer: the holy grail?
    J Natl Cancer Inst. 2014 Oct;106(10). pii: dju297. doi: 10.1093/jnci/dju297 PMID: 25269490
  25. Database integration of 4923 publicly-available samples of breast cancer molecular and clinical data.
    AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:138-42 PMID: 24303324
  26. Opinion: Reproducible research can still be wrong: adopting a prevention approach.
    Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1645-6 PMID: 25670866
Article Info
Journal
Genome medicine
Abbr.
Genome Med
ISSN
1756-994X
Published
2016-03-09
Epub
2016-00-09
Pages
27
Language
English
Region
England
NLM ID
101475844
PMCID
PMC4784276
Subset
IM
Grants
NIBIB NIH HHS · R01 EB020527 · United States
NLM NIH HHS · T15 LM007033 · United States
NLM NIH HHS · T15LM007033 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com